Merck said on Wednesday a combination of its experimental drug and blockbuster therapy Keytruda failed a late-stage trial ...

Yoshiaki Nakamura, MD, PhD, discusses how the use of tissue-free circulating tumor DNA (ctDNA) analysis for detecting minimal residual disease (MRD) can enhance the prediction of recurrence in stage ...

After facing colorectal cancer for nearly eight years, Mandy Wilk got a double-lung transplant in June at Northwestern. She ...

Research has revealed how disruption of the circadian clock, the body's internal, 24-hour biological pacemaker, may accelerate the progression of colorectal cancer by affecting the gut microbiome and ...

Medical experts discuss how to frame the conversation with patients about third-line metastatic colorectal cancer treatment ...

Symptoms of anaemia include fatigue, cold hands and feet, hair loss, brittle nails, cognitive issues like brain fog, ...

Totò Schillaci, who passed away today, September 18, had been suffering from colon cancer for some time. His condition had ...

Surgeons at Chicago's Northwestern Medicine gave Mandy Wilk, a cancer patient, a first-of-its-kind double lung transplant.

Colon cancer is increasingly affecting the younger population. It's essential to be informed about the risk factors and ...

Merck & Co.’s stock fell 0.5% premarket Wednesday, after the drug company said a late-stage trial of its blockbuster cancer drug Keytruda in combination with favezelimab failed to meet the main goal ...

Adjuvant cancer treatments such as chemotherapy and radiation are given after a primary cancer treatment to help prevent ...

Americans have benefited from huge leaps in breast cancer treatment over the last two decades, but diagnoses are becoming ...